The epidermal growth factors (EGF) market consists of cosmetic products that are used to stimulate the production of collagen and new cell growth in the skin. EGF is a glycoprotein that induces cell proliferation and differentiation by binding to EGF receptors on the cell surface. It is commonly found in plant oils such as lavender and rosehip. EGF products are usually formulated as serums, ampoules, or creams to reduce the appearance of fine lines, wrinkles, and other signs of aging. They are increasingly being used in anti-aging skincare routines due to their ability to promote skin cell regeneration. The Global Epidermal Growth Factors (EGF) Market is estimated to be valued at US$ 1,349.6 Mn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the epidermal growth factors (EGF) market are Radiant Inc., Pavay, BIO-FD&C Co. Ltd., BIOEFFECT, LipoTrue, S.L., and Ytkangdaer. The rising consumer base of working professionals and increasing spending capacity on premium anti-aging products is fueling the growth of the EGF market. Technological advancements such as microencapsulation and nano-emulsions have helped enhance the efficacy and delivery of EGF in cosmetic formulations.
Market Trends
Increasing demand for natural and plant-based cosmetic ingredients - More consumers are opting for skincare products containing natural active ingredients over synthetic alternatives due to health and environmental concerns. This has driven many cosmetic brands to incorporate more plant-based growth factors like lavender and rosehip oils that contain EGF.
Multi-functional anti-aging products - Cosmetic manufacturers are developing multi-purpose anti-aging creams, serums and gels containing a combination of ingredients like hyaluronic acid, peptides, retinol along with EGF to target multiple signs of skin aging such as wrinkles, dark spots and loss of elasticity.
Market Opportunities
Male grooming products - While the anti-aging skin care market is dominated by women, male consumers are increasingly willing to spend on anti-aging face creams, gels and moisturizers. Incorporating EGF in targeted male-grooming products can capture this emerging opportunity.
E-commerce market - Online sales of premium cosmetic products have grown significantly during the pandemic. EGF-based brands can strengthen their omnichannel presence and tap international markets through strategic collaborations with e-retail platforms.
Impact of COVID-19 on Epidermal Growth Factors (EGF) Market Growth
The COVID-19 pandemic has significantly impacted the growth of the global epidermal growth factors (EGF) market. During the initial outbreak, lockdowns and supply chain disruptions negatively affected the market. There was a steep decline in demand from the cosmetics industry as people stayed indoors. Clinical trials involving EGF therapeutics also faced delays. However, as the pandemic intensified, the demand for EGFs rose from the biopharmaceutical sector. Researchers fast-tracked various trials investigating EGF's potential role in COVID-19 treatment. Several studies explored if EGF could help reduce acute lung injury caused by SARS-CoV-2. Overall, though the cosmetics demand fell initially, the biopharma demand provided resilience to the market. Going forward, increased focus on skincare and immunity boosting products post-pandemic is likely to drive new growth opportunities. Further research on EGF's clinical benefits will also support market expansion in the long-run despite facing initial setbacks due to the coronavirus disruption.
Epidermal Growth Factors (EGF) Market in North America
In terms of value, North America accounted for the largest share of the global EGF market in 2024. The region has been at the forefront of clinical research involving EGF therapeutics for conditions like chronic wounds and lung diseases. availability of advanced healthcare infrastructure and growing biotechnology industry in the US and Canada have boosted market growth. States like California, Massachusetts and Maryland are major hubs of EGF development and manufacturing activities. Moreover, with rising health consciousness, skin and hair care products containing EGF also witnessed rising demand, driving the cosmetics market in North America. The region is anticipated to remain the most lucrative market due to continued product innovations and R&D investments.
Fastest Growing Region for Epidermal Growth Factors (EGF) Market
The Asia Pacific region, excluding Japan, is projected to be the fastest growing region in the global EGF market during the forecast period from 2023 to 2030. This is attributed to factors such as rising geriatric populations, increasing healthcare expenditure, growing cosmetic industry and expanding biotech sectors in various countries. In particular, China and India are emerging as highly promising markets. Rising incomes, greater product awareness and expanding middle-class consumer bases are propelling the demand for premium skincare brands with EGF-infused offerings. Additionally, governments across Asia Pacific are prioritizing healthcare reforms and funding clinical trials, fuelling research opportunities for EGF therapeutics.
Sign in to leave a comment.